ASTELLAS PHARMA, INC. (ALPMF)
Clinical trial NCT03505320 updates: 1. completion date: 2027-05-31 → 2027-11-30 2. primary completion date: 2026-07-31 → 2026-12-31
Clinical trial NCT03505320 updates: 1. completion date: 2027-05-31 → 2027-11-30 2. primary completion date: 2026-07-31 → 2026-12-31
📉 **NEGATIVE** • Medium confidence analysis (69%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (20%) **Content type:** Clinical